Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2720]
News [7073]
Articles [271]
Editorials [8]
Conferences [215]
elearning [41]
Next generation sequencing and WIN therapeutics
Dr Michael Pellini – Foundation Medicine, Cambridge, USA
Next generation sequencing and WIN therapeutics ( Dr Michael Pellini – Foundation Medicine, Cambridge, USA )
6 Jul 2012
Identifying targets with systems medicine
Dr Leroy Hood – Institute for Systems Biology, USA
Identifying targets with systems medicine ( Dr Leroy Hood – Institute for Systems Biology, USA )
6 Jul 2012
Importance of early detection and the ‘Beyond the Shock’ programme
Dr Douglas Feil – National Breast Cancer Foundation, USA
Importance of early detection and the ‘Beyond the Shock’ programme ( Dr Douglas Feil – National Breast Cancer Foundation, USA )
6 Jul 2012
Shortening the timeline for clinical drug developments
Dr James Doroshow – National Cancer Institute, Bethesda, USA
Shortening the timeline for clinical drug developments ( Dr James Doroshow – National Cancer Institute, Bethesda, USA )
6 Jul 2012
Building international collaborations and the WINTHER trial
Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA
Building international collaborations and the WINTHER trial ( Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA )
6 Jul 2012
Identifying drug sensitivity and resistance in acute myeloid leukaemia
Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA
Identifying drug sensitivity and resistance in acute myeloid leukaemia ( Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA )
27 Jun 2012
Mouse models and proteomics tackling acute lymphoblastic leukaemia
Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland
Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )
25 Jun 2012
Assessing iron overload and toxicity
Prof John Porter - University College London, UK
Assessing iron overload and toxicity ( Prof John Porter - University College London, UK )
25 Jun 2012
BRCA carrier status as a prognostic factor for prostate cancer
Dr Elena Castro - The Institute of Cancer Research, Sutton, UK
BRCA carrier status as a prognostic factor for prostate cancer ( Dr Elena Castro - The Institute of Cancer Research, Sutton, UK )
20 Jun 2012
Effects of age on treatment and outcomes in women with stage IB-IIB cervical...
Dr Don Dizon – Brown University, Providence, USA
Effects of age on treatment and outcomes in women with stage IB-IIB cervical cancer ( Dr Don Dizon – Brown University, Providence, USA )
19 Jun 2012
Novel PET tracers and their future use in assessment of response to treatment
Dr Andrei Iagaru – Stanford University, CA, USA
Novel PET tracers and their future use in assessment of response to treatment ( Dr Andrei Iagaru – Stanford University, CA, USA )
17 Jun 2012
Role of family history and genetic testing in diagnosis
Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation